HINT3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.852800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.522000E-01
Normal-vs-Stage2
2.551400E-01
Normal-vs-Stage3
1.238990E-01
Normal-vs-Stage4
6.940200E-01
Stage1-vs-Stage2
3.725800E-01
Stage1-vs-Stage3
1.994400E-01
Stage1-vs-Stage4
9.983000E-01
Stage2-vs-Stage3
2.366600E-01
Stage2-vs-Stage4
4.581200E-01
Stage3-vs-Stage4
7.766100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.578800E-01
Normal-vs-AfricanAmerican
6.830400E-01
Normal-vs-Asian
2.218800E-01
Caucasian-vs-AfricanAmerican
1.838440E-02
Caucasian-vs-Asian
5.744600E-01
AfricanAmerican-vs-Asian
3.431900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.256000E-01
Normal-vs-Female
3.803400E-01
Male-vs-Female
5.041400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.944400E-01
Normal-vs-Age(41-60Yrs)
4.015600E-01
Normal-vs-Age(61-80Yrs)
2.724000E-01
Normal-vs-Age(81-100Yrs)
2.479600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.526800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.460600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.972800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.182800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.054600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.002800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.265980E-01
Normal-vs-Daily Drinker
1.357390E-01
Normal-vs-Weekly Drinker
2.008000E-01
Normal-vs-Occasional Drinker
5.757400E-01
Normal-vs-Social Drinker
4.587000E-01
Non Drinker-vs-Daily Drinker
5.384000E-01
Non Drinker-vs-Weekly Drinker
9.246000E-01
Non Drinker-vs-Occasional Drinker
1.844160E-01
Non Drinker-vs-Social Drinker
4.712200E-01
Daily Drinker-vs-Weekly Drinker
5.762800E-01
Daily Drinker-vs-Occasional Drinker
1.177040E-01
Daily Drinker-vs-Social Drinker
3.030200E-01
Weekly Drinker-vs-Occasional Drinker
3.376400E-01
Weekly Drinker-vs-Social Drinker
6.202600E-01
Occasional Drinker-vs-Social Drinker
6.920800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.720200E-02
Normal-vs-Grade 2
2.038300E-02
Normal-vs-Grade 3
2.803800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.013400E-01
Grade 1-vs-Grade 3
2.839000E-01
Grade 1-vs-Grade 4
4.720200E-02
Grade 2-vs-Grade 3
7.909200E-01
Grade 2-vs-Grade 4
2.038300E-02
Grade 3-vs-Grade 4
2.803800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.500000E-01
Normal-vs-NonDiabetic
2.041000E-01
Diabetic-vs-NonDiabetic
9.547200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.935600E-01
Normal-vs-NoPancreatitis
2.297200E-01
Pancreatitis-vs-NoPancreatitis
6.538200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.828800E-01
Normal-vs-N1
2.608400E-01
N0-vs-N1
5.213800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.126200E-01
Normal-vs-TP53-NonMutant
6.460400E-01
TP53-Mutant-vs-TP53-NonMutant
9.510100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
